Newsweek Highlights Lucem Health’s Approach to Earlier Type 1 Diabetes Detection
Lucem Health featured in Newsweek for using EHR data to identify early-stage type 1 diabetes, helping reduce preventable DKA and improve follow-up care.
2026 Life Sciences Prediction: Conrad Gudmundson Featured in HealthIT Answers
Conrad Gudmundson featured in HealthIT Answers’ expert opinions on life sciences in 2026 and what may come next for the industry.
2026 Interoperability: Lucem Health Perspective Featured in HealthIT Answers
HealthIT Answers features Lucem Health CCO Conrad Gudmundson sharing his 2026 interoperability prediction.
Sean Cassidy Discusses Clinical AI on the Empowered Patient Podcast
Lucem Health CEO Sean Cassidy joins Karen Jagoda on the Empowered Patient Podcast to discuss how clinical AI is enabling early disease detection for conditions like Type 1 Diabetes and cancer.
In the News: How AI in Specialty Care is Reshaping Margins and Referrals
Lucem Health CEO Sean Cassidy speaks with Healthcare IT News about how AI in specialty care can optimize patient mix, improve margins, and drive new shared-risk vendor models.
Lucem Health Wins Rising Star for AI in Health Operations at the Digital Health Hub Awards @ HLTH
Lucem Health has been named the Rising Star Winner for [...]
Lucem Health Featured in Yahoo Finance Coverage of iRhythm’s Growth Strategy
Yahoo Finance mentions Lucem Health–iRhythm partnership that accelerates early arrhythmia detection and data-driven care.
Sean Cassidy Featured in Patient Safety & Quality Healthcare (PSQH)
PSQH feature: Our CEO explains how the new federal spending law pressures health systems to act fast on costs, Medicaid, and service-line strategy.
Lucem Health announces new initiative to accelerate early detection of Type 1 Diabetes (T1D)
Lucem Health launches Reveal for T1D, using AI and EHR data to identify early-stage T1D, backed by Sanofi to improve diagnosis and outcomes.
Lucem Health Featured in Charlotte Business Journal
Lucem Health featured in Charlotte Business Journal—raised $2.3M to advance AI disease detection and expand its team over the next year.
